Primary cell culture of gliomas, and construction of patient-derived xenograft (PDX) model
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SUZHOU GENHOUSE PHARMA RES & DEV CO LTD
- Publication Date
- 2018-10-23
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedicine, in particular to a glioma primary cell culture and a glioma PDX standardized model library. Background technique
[0002] The traditional in vivo drug susceptibility testing method is to screen mouse or human cells in vitro, subculture to establish a stable cell line, and then transplant into mice to establish a tumor model. The application of this model in tumor research has been established. There have been half a century, but this model has certain defects, because the tumor cell lines that have been continuously passaged have adapted to the environment of the external culture dish and lost tumor heterogeneity, so they cannot objectively reflect the situation of the primary tumor. PDX model is a kind of transplantation of patient's fresh tumor cells or tissues directly into immunodeficient mice through orthotopic or heterotopic (mostly subcutaneous or renal capsule), and relying on the environment p...